Determining Therapeutic Susceptibility in Multiple Myeloma by Single-Cell Mass Accumulation

Nature Communications - United Kingdom
doi 10.1038/s41467-017-01593-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

Evolving Therapeutic Role of Bisphosphonates in Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2005English

HDAC3 Regulates DNMT1 Expression in Multiple Myeloma: Therapeutic Implications

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2012English

FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

A Simplified Method for Stem Cell Autografting in Multiple Myeloma: A Single Institution Experience

Bone Marrow Transplantation
TransplantationHematology
2009English

Four Proteins Governing Overangiogenic Endothelial Cell Phenotype in Patients With Multiple Myeloma Are Plausible Therapeutic Targets

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Multiple Myeloma Presenting With External Ear Canal Mass

Journal of Laryngology and Otology
MedicineOtorhinolaryngology
1998English

Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy